Vertex Pharmaceuticals Inc financials at a glance

Year Year 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2021 2022 2023 2024
Rev. Revenue
$6.21B $4.16B $3.05B $2.49B $1.70B $1.03B $580.42M $1.21B $1.53B $1.41B $143.37M $101.89M $175.50M $199.01M $216.36M $160.89M $102.72M $7.57B $8.93B $9.87B $0.00M
GM % Gross Margin %
58.65% 44.69% 40.08% 35.72% 26.09% -8.53% -57.90% 16.47% 31.52% 44.12% -17.69% -60.18% 2.18% -40.65% -80.90% 6.52% 6.42% 47.78% 59.60% 55.16% 0.00%
OM Operating Margin
46.24% 28.87% 21.79% 15.78% 0.66% -45.01% -110.52% -12.92% 3.18% 15.72% 0.00% 0.00% -261.18% -207.36% -104.17% -88.10% -133.60% 36.69% 49.03% 43.65% 0.00%
EPS Earnings Per Share
$-1.65 $-1.86 $-3.03 $-3.27 $-3.64 $-3.48 $-0.50 $1.18 $-1.58 $-2.17 $-1.11 $0.85 $1.95 $4.08 $5.33 $10.32 $13.02 $14.88 $15.23 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0.00% 0.00% 0.00% 0.00% 0.00% -0.00% -0.00% -0.00% 0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% 0 0.00% 0.00% 0.00% 0
Sha. Shares
260.04m 257.15m 255.56m 252.9m 248.03m 245.72m 240.52m 233.76m 216.83m 208.57m 203.19m 193.9m 150.47m 132.3m 125.59m 108.02m 80.31m 254.25m 254.58m 0m 258.31m
OCF Operating Cash Flow
$3.25B $1.57B $1.27B $844.94M $236.10M $-365.43M $-573.11M $-60.67M $267.84M $143.74M $-635.44M $-427.59M $-226.48M $-252.48M $-22.48M $-172.05M $-142.12M $2.64B $4.13B $3.54B $0.00M
FCF Free Cash Flow
$2.99B $1.49B $1.17B $745.52M $179.54M $-410.73M $-564.40M $-102.96M $196.70M $109.14M $-673.50M $-451.09M $-258.66M $-284.90M $-54.90M $-189.01M $-154.66M $2.41B $3.93B $3.53B $0.00M
FCFS Free Cash Flow Per Share
$11.52 $5.82 $4.62 $2.35 $0.73 $-2.03 $-2.65 $-0.76 $0.93 $0.53 $-3.36 $-2.60 $-1.84 $-2.21 $-0.48 $-2.12 $-1.97 $9.35 $15.33 $12.72 $0.00